Concepedia
Statistics
Publications
16
Citations
784
H-Index
13
Active since
2009
Affiliations
Pfizer (United States)(Current)
University of Alabama at Birmingham
Harvard University
Eric Zhang is an author at Pfizer (United States) specializing in pharmacology, life sciences, and pi3k inhibitors.
Publications per year
2009–2024
Circulating myocardial microRNAs from infarcted hearts are carried in exosomes and mobilise bone marrow progenitor cells
Min Cheng, Junjie Yang, Xiaoqi Zhao et al. · Nature Communications · 2019 · 233 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +17
PF-04691502, a Potent and Selective Oral Inhibitor of PI3K and mTOR Kinases with Antitumor Activity
Jing Yuan, Pramod P. Mehta, Min-Jean Yin et al. · Molecular Cancer Therapeutics · 2011 · 161 citations · Full text
Medicine, Oncology, Pharmacology +16
Discovery of the highly potent PI3K/mTOR dual inhibitor PF-04691502 through structure based drug design
Hengmiao Cheng, Shubha Bagrodia, Simon Bailey et al. · MedChemComm · 2010 · 73 citations · Full text
Pharmacy, Oncology, Pharmacology +17
Structural basis of HLX10 PD-1 receptor recognition, a promising anti-PD-1 antibody clinical candidate for cancer immunotherapy
Hassan Issafras, Shilong Fan, Chi-Ling Tseng et al. · PLoS ONE · 2021 · 53 citations · Full text
Design and synthesis of a novel pyrrolidinyl pyrido pyrimidinone derivative as a potent inhibitor of PI3Kα and mTOR
Phuong Le, Hengmiao Cheng, Sacha Ninkovic et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 36 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +14
1–5 of 16